Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular dose-response to supplemental oxygen in healthy volunteers
2016-002342-23Phase 4Completed
- Sponsor
- VU University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxygen, sponsored by VU University Medical Center. Primary endpoint: Change in perfused vessel density of small vessels. Started Jul 2016; status: completed.
02
Drugs
oxygen
Beyond the preview
Go deeper on 2016-002342-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002342-23.